Treatment type: Immunotherapies
-
New arrivals boost Hudson’s inflammation research leadership
Hudson Institute’s reputation as a leader in inflammation research has been boosted by the appointment of two specialists in the field.… Read more
-
Funding turbocharges search for children’s brain cancer cure
A deadly form of children’s brain cancer that’s immune to chemotherapy is the target of new research at Hudson Institute, looking at the epigenome and immuno-therapies for answers.… Read more
-
Better treatments sooner – Hudson’s new RNAte Platform unveiled
Hudson Institute of Medical Research today officially unveiled its world-first RNAte platform that could see vaccines and therapeutic treatments developed faster by being able to rapidly assess their potential inflammation side effects, right here in Victoria.… Read more
-
Controlling inflammation to conquer lung infections
A new treatment that controls the body’s response to influenza virus is shaping as the key to preventing dangerous lung inflammation and damage.… Read more
-
Bacteria and stomach cancer: breaking the link
H. pylori – short for Helicobacter pylori – colonises the stomach and is known to be linked to the development of stomach cancer. It is estimated that over half of the world’s population is infected with H. pylori, making it one of the most common bacterial infections.… Read more
-
How does cell death trigger inflammation?
Inflammation is at the heart of numerous diseases and new research has found that the exact time an innate immune cell dies is crucial to the inflammatory process.… Read more
-
How to protect the newborn brain
A major systematic review of treatments for protecting the newborn brain from the negative effects of inflammation has found that earlier anti-inflammatory intervention is best, but it’s better late than never.… Read more
-
Can the body’s signalling protein be harnessed to stop ovarian cancer?
The search for preventions and cures has turned inward – focussing on the immune system to stop ovarian cancer.… Read more
-
RSV 2023 – what you need to know
Last year respiratory syncytial virus (RSV) in infants and children shot up, causing record numbers of hospitalisations. Respiratory virus expert, Associate Professor Michelle Tate share’s what you need to know about RSV in 2023.… Read more
-
Flu season 2023 – all your questions answered
Influenza expert, A/Prof Michelle Tate shares everything that you need to know for the 2023 flu season, including who is most at risk. … Read more